| Date | Time | Source | Headline | Symbol | Company |
| 19/07/2013 | 05:30 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(2) (424b2) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 19/07/2013 | 05:30 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 19/07/2013 | 05:06 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 19/07/2013 | 05:04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 19/07/2013 | 05:03 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 19/07/2013 | 05:02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 19/07/2013 | 05:02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 19/07/2013 | 04:58 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 19/07/2013 | 04:57 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 19/07/2013 | 04:56 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 19/07/2013 | 04:55 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 19/07/2013 | 04:53 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 19/07/2013 | 04:52 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 19/07/2013 | 04:50 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 19/07/2013 | 03:49 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 19/07/2013 | 03:48 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 19/07/2013 | 03:48 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 19/07/2013 | 03:48 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 19/07/2013 | 03:47 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 19/07/2013 | 03:47 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 19/07/2013 | 03:46 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 19/07/2013 | 01:39 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 17/07/2013 | 03:43 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 17/07/2013 | 02:00 | PR Newswire (US) | Omthera Stockholders Approve Acquisition by AstraZeneca | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 11/07/2013 | 23:13 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 11/07/2013 | 07:07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 09/07/2013 | 23:59 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 09/07/2013 | 23:59 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 09/07/2013 | 20:00 | PR Newswire (US) | Omthera Pharmaceuticals Announces NDA Submission for Epanova™ for the Treatment of Patients with Very High Triglycerides | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 28/06/2013 | 01:54 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
